Authorised users need to be logged in to read this content.
Type 2 diabetes: potential cardiovascular and mortality benefits with empagliflozin treatment in high-risk individuals (Oct-15)
Authorised users need to be logged in to read this content.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 19th March 2012 This Rapid Review aims to clarify the DVLA requirements and advice for the monitoring of blood glucose in people with diabetes. It is based on the […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 24 October 2011 A UK study found that if all analogue insulin dispensed in the UK between 2000 and 2009 had been for human insulin alternatives, the NHS would […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 19 October 2011 From a date to be announced in October 2011, DVLA rules are changing to allow people with insulin-treated diabetes to apply for a group 2 vehicle […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 September 2011 A Cochrane review of 20 randomised controlled trials (RCTs) found that intensive blood glucose control did not significantly reduce all-cause mortality or cardiovascular (CV) mortality, compared […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 12 August 2011 The ADDITION-Europe study looked at the effect of early intensive multifactorial management (of HbA1c, blood pressure, cholesterol; and prescription of aspirin) on 5-year cardiovascular outcomes in […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 16 June 2011 This meta-analysis of 13 RCTs (n=17,627) found the use of glitazones was associated with an increased risk of pneumonia or lower respiratory tract infection (LRTI) in […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 28th March 2011 The ROADMAP trial found olmesartan delayed the onset of microalbuminuria in patients with type 2 diabetes and normoalbuminuria. While this disease-oriented outcome (DOO) suggested a potential benefit […]